Φορτώνει......
Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
Bevacizumab, a VEGF‐targeting monoclonal antibody, may trigger an infiltrative growth pattern in glioblastoma. We investigated this pattern using both a human specimen and rat models. In the human specimen, a substantial fraction of infiltrating tumor cells were located along perivascular spaces in...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Inc.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590500/ https://ncbi.nlm.nih.gov/pubmed/30414187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31983 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|